Cargando…
Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
BACKGROUND AND AIMS: Gastric cancer is the fifth most diagnosed malignant tumor worldwide with limited effective chemotherapy. Ferroptosis is a new type of programmed cell death, which is becoming as a novel therapeutic target for tumors. Arenobufagin (ArBu) is a bufadienolide isolated from toad ski...
Autores principales: | Chen, Ke, Li, Angling, Wang, Jian, Li, Dongchang, Wang, Xiaoshan, Liu, Chengwei, Wang, Zhengguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845647/ https://www.ncbi.nlm.nih.gov/pubmed/36685074 http://dx.doi.org/10.1016/j.jtcme.2022.10.007 |
Ejemplares similares
-
Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
por: Liu, Chengwei, et al.
Publicado: (2023) -
Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
por: Ke, Chen, et al.
Publicado: (2022) -
RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer
por: Wang, Xiaoshan, et al.
Publicado: (2021) -
REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer
por: Wang, Xiaoshan, et al.
Publicado: (2018) -
Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)